Monopar Therapeutics (MNPR) Treasury Shares (2020 - 2025)
Monopar Therapeutics (MNPR) reported Treasury Shares of $175634.0 for Q4 2025, up 331.12% on a YoY basis from $40739.0 in Q4 2024, and up 53.24% sequentially from $114610.0 in Q3 2025.
Monopar Therapeutics (MNPR) Treasury Shares (2020 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 6 years of Treasury Shares data on file, last reported at $175634.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 331.12% year-over-year to $175634.0; the trailing twelve-month figure through Dec 2025 stood at $175634.0 (up 331.12% YoY), and the FY2025 full-year result was $175634.0, up 331.12% from the prior year.
- Treasury Shares rose to $175634.0 in Q4 2025, from $114610.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $525565.0 in Q2 2023 to a low of $40739.0 in Q4 2024.
- A 5-year average of $218852.2 and a median of $149364.0 in 2025 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares tumbled 89.86% in 2024 and soared 331.12% in 2025, its largest moves.
- Tracing MNPR's Treasury Shares over 5 years: stood at $111462.0 in 2021, then tumbled by 51.08% to $54529.0 in 2022, then soared by 53.34% to $83617.0 in 2023, then slumped by 51.28% to $40739.0 in 2024, then soared by 331.12% to $175634.0 in 2025.
- Business Quant data shows MNPR's Treasury Shares at $175634.0 in Q4 2025, $114610.0 in Q3 2025, and $128408.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 34.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 5.14 Mn |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | 175,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175,634.00 |
| Dec 31, 2025 | 175,634.00 |
| Sep 30, 2025 | 114,610.00 |
| Sep 30, 2025 | 114,610.00 |
| Jun 30, 2025 | 128,408.00 |
| Jun 30, 2025 | 128,408.00 |
| Mar 31, 2025 | 149,364.00 |
| Mar 31, 2025 | 149,364.00 |
| Dec 31, 2024 | 40,739.00 |
| Dec 31, 2024 | 40,739.00 |
| Sep 30, 2024 | 47,843.00 |
| Sep 30, 2024 | 47,843.00 |
| Jun 30, 2024 | 349,154.00 |
| Jun 30, 2024 | 349,154.00 |
| Mar 31, 2024 | 366,534.00 |
| Mar 31, 2024 | 366,534.00 |
| Dec 31, 2023 | 83,617.00 |
| Dec 31, 2023 | 83,617.00 |
| Sep 30, 2023 | 471,828.00 |
| Sep 30, 2023 | 471,828.00 |